Genetic Causes of Gestational Diabetes in the Emirati Population
NCT ID: NCT03589092
Last Updated: 2020-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2017-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic and Epigenetic Mechanisms of Developing Gestational Diabetes Mellitus and Its Effects on the Fetus
NCT03610178
Stratification of Risk of Diabetes in Early Pregnancy
NCT03005600
Diabetes Mellitus With Pregnancy in Benisuef Localities
NCT03169205
Lifestyle Intervention for Prevention of Gestational Diabetes Mellitus in the UAE Population
NCT04273412
Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes
NCT02556840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GDM Current
Currently pregnant women diagnosed with GDM.
Next generation sequencing (NGS) methodologies will used on individuals suspected of genetic diabetes.
Next generation sequencing (NGS)
NGS Panel, Whole exome/genome sequencing
GDM History
Women with history of GDM (with negative GAD/IA2 antibodies if results available).
Next generation sequencing (NGS) methodologies will used on individuals suspected of genetic diabetes.
Next generation sequencing (NGS)
NGS Panel, Whole exome/genome sequencing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Next generation sequencing (NGS)
NGS Panel, Whole exome/genome sequencing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women with history of GDM (with negative GAD/IA2 antibodies if results available).
Exclusion Criteria
* Women genetically diagnosed as MODY
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London Diabetes Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maha Barakat, PhD FRCP
Role: PRINCIPAL_INVESTIGATOR
Imperial College London Diabetes Centre
Torben Hansen, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London Diabetes Centre
Abu Dhabi, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IREC032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.